Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suzhou Panomic Biomedical Technology

Request full access

A biotech company providing a wide range of state-of-the-art, research-grade assays trusted by clinicians and scientists

Suzhou Shi, ChinaFounded 2013Biotech & Life Sciences

About Suzhou Panomic Biomedical Technology

Suzhou Panomic Biomedical Technology, also known as PANOMIX, was established in 2013 within the Suzhou Industrial Park. The company's core team hails from prestigious institutions such as Harvard University, MD Anderson Cancer Center, and the Chinese Academy of Sciences. As a contract research organization (CRO), PANOMIX specializes in metabolomics technology, offering comprehensive solutions for precision medicine and nutrition. The firm operates across several business segments, including scientific research services, industrial services, new drug support, and clinical detection. Its client base consists of universities, research institutes, hospitals, and various enterprises, serving over 1,000 customers.

The company's business model is centered on providing data analysis services and a wide array of research-grade assays. PANOMIX is equipped with over 80 advanced mass spectrometry systems, enabling it to deliver more than 100 distinct detection and analysis services and over 20 clinical detection products. Its service portfolio is extensive, featuring global untargeted metabolomics, targeted metabolomics, lipidomics, proteomics, and multi-omics integrated analysis. A key offering is its independently developed "Global untargeted metabolomics" technology platform and the BioDeepTM cloud data analysis system, which together form an integrated platform for metabolomics research. The company also develops products for diagnosing and screening cardiovascular diseases, strokes, and tumors.

Financially, the company is classified as a Series A startup. It has secured significant investment to fuel its growth, completing a funding round on April 29, 2021, that raised $15.4 million. This positions PANOMIX to continue its focus on the research and clinical application development of metabolomics technology.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
24.3/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jun 2023 $14M $75M Oriza Holdings · Leading Venture Capital · Yuansheng BioVenture ↗
SERIES A✓Equity / VC May 2021 $15M $60M YuanBio Venture Capital —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Suzhou Panomic Biomedical Technology website traffic

Latest recorded traffic for Suzhou Panomic Biomedical Technology is 330 monthly website visits. Suzhou Panomic Biomedical Technology's team declined 50% over the past year.

Latest monthly visits330 1-year team growth-50%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Suzhou Panomic Biomedical Technology in the Suzhou Shi ecosystem

Live from Dealroom

The Suzhou Panomic Biomedical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • YuanBio Venture Capital
  • Oriza Holdings
  • Leading Venture Capital
  • Yuansheng BioVenture
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇸🇬 Singapore100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suzhou Panomic Biomedical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Panomic Biomedical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.